2'3'-cGAMP (sodium salt): Precision STING Agonist for Inn...
2'3'-cGAMP (sodium salt): Precision STING Agonist for Innate Immunity and Cancer Immunotherapy
Executive Summary: 2'3'-cGAMP (sodium salt) is a naturally occurring cyclic dinucleotide synthesized by cGAS in response to cytosolic DNA, acting as a direct, high-affinity ligand (Kd = 3.79 nM) for the stimulator of interferon genes (STING) protein [APExBIO]. Upon STING activation, it triggers a cascade leading to TBK1/IRF3 pathway engagement and robust type I interferon (IFN-β) production (Shaji et al. 2024). Compared to other cyclic dinucleotides, 2'3'-cGAMP displays the highest binding affinity for mammalian STING (Shaji et al. 2024). Its chemical stability and water solubility (≥7.56 mg/mL) facilitate reproducible assay integration. This molecule is an essential tool for evaluating STING-targeted immunotherapeutics and elucidating innate immune mechanisms (APExBIO).
Biological Rationale
2'3'-cGAMP (sodium salt) is an endogenous second messenger produced in mammalian cells by cyclic GMP-AMP synthase (cGAS) upon detection of cytosolic double-stranded DNA (Shaji et al. 2024). This molecule acts as a central node in the cGAS-STING signaling pathway, a highly conserved axis of innate immunity. The pathway is vital for initiating type I interferon responses, which are essential for antiviral defense and tumor surveillance. The unique 2'-5' and 3'-5' phosphodiester linkages in 2'3'-cGAMP confer enhanced affinity and selectivity for the mammalian STING receptor compared to bacterial cyclic dinucleotides (Shaji et al. 2024). Dysregulation or targeted modulation of this pathway is implicated in autoimmunity, cancer, and infectious diseases, underscoring the molecule's broad relevance.
Mechanism of Action of 2'3'-cGAMP (sodium salt)
Upon cytosolic DNA detection, cGAS synthesizes 2'3'-cGAMP from ATP and GTP. 2'3'-cGAMP binds directly to STING, an ER-resident adapter protein. This binding induces a conformational change that facilitates STING trafficking to the Golgi apparatus. STING recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). Phosphorylated IRF3 translocates to the nucleus, driving transcription of type I interferon genes, including IFN-β. The resulting cytokine response leads to enhanced antigen presentation and recruitment of T cells to the tumor or infection site (Shaji et al. 2024). 2'3'-cGAMP (sodium salt) exhibits a Kd of 3.79 nM for STING, indicating strong, specific interactions crucial for downstream signaling fidelity. The sodium salt form, provided by APExBIO, increases aqueous solubility and experimental reproducibility.
Evidence & Benchmarks
- 2'3'-cGAMP is the natural, high-affinity ligand of mammalian STING, with a Kd of 3.79 nM (Shaji et al. 2024, DOI).
- In a syngeneic mouse model, lipid nanoparticle-encapsulated 2'3'-cGAMP significantly reduced pancreatic tumor burden (Shaji et al. 2024, DOI).
- Intratumoral administration of 2'3'-cGAMP led to increased type I interferon and chemokine production, promoting both innate and adaptive immune activation (Shaji et al. 2024, DOI).
- 2'3'-cGAMP outperforms other cyclic dinucleotides (CDNs) for STING activation in mammalian systems due to its unique phosphodiester linkages (Shaji et al. 2024, DOI).
- Product stability is maintained at -20°C, with solubility in water ≥7.56 mg/mL; insoluble in ethanol and DMSO (APExBIO).
For additional comparative analysis of 2'3'-cGAMP (sodium salt) with other STING agonists, see this article, which focuses on potency and reproducibility; the present article uniquely details mechanistic and translational benchmarks.
Applications, Limits & Misconceptions
2'3'-cGAMP (sodium salt) is widely used to study STING-mediated innate immunity, cancer immunotherapy, and antiviral responses. Its specificity for mammalian STING, along with robust water solubility, supports applications in:
- Immunology and inflammation research: Dissecting cGAS-STING pathway signaling and cross-talk.
- Cancer biology: Investigating tumor microenvironment modulation and immune cell recruitment.
- Antiviral studies: Modeling interferon responses to cytosolic DNA from pathogens.
- Drug screening: Benchmarking of STING agonists or antagonists.
For a deeper dive into endothelial-specific effects and clinical translation, see this review, which explores new frontiers; this current article clarifies standardized use parameters and molecular mechanisms.
Common Pitfalls or Misconceptions
- 2'3'-cGAMP (sodium salt) is ineffective in species lacking a functional STING pathway (e.g., some rodent strains).
- It does not cross cell membranes efficiently by itself; delivery vehicles (e.g., lipid nanoparticles) are required for in vivo or ex vivo cellular uptake (Shaji et al. 2024).
- Not all type I interferon responses are STING-dependent; parallel pathways (e.g., RIG-I/MAVS) can confound results if not controlled.
- Solubility in water does not guarantee solubility in complex media; precipitation can occur at high concentrations or in incompatible buffers.
- Storage above -20°C reduces stability and may degrade biological activity (APExBIO).
Workflow Integration & Parameters
2'3'-cGAMP (sodium salt) from APExBIO (SKU: B8362) is supplied as a chemically defined solid (C20H22N10Na2O13P2; MW 718.37). It should be dissolved in sterile water to a working concentration (≥7.56 mg/mL) and stored at -20°C for long-term stability. Avoid exposure to repeated freeze-thaw cycles. For cellular assays, direct addition is possible for permeabilized cells; otherwise, use electroporation, carrier peptides, or lipid nanoparticles for cytosolic delivery. For in vivo studies, encapsulation in lipid nanoparticles or other delivery vehicles is strongly recommended to ensure cytosolic access and pharmacokinetic stability (Shaji et al. 2024). For a mechanistic perspective on precise cellular modulation, see this resource, which complements this article by focusing on cell-type targeting strategies.
Conclusion & Outlook
2'3'-cGAMP (sodium salt) remains the gold-standard STING agonist for mechanistic, translational, and preclinical research in innate immunity and cancer immunotherapy. Its high binding affinity, chemical stability, and defined solubility parameters enable robust, reproducible experimental outcomes. As new delivery modalities and clinical applications emerge, this molecule will continue to inform immunotherapeutic strategy optimization. For full product details and ordering, see the APExBIO 2'3'-cGAMP (sodium salt) page.